Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc. et al
Plaintiff: Cipla Ltd.
Defendant: Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG
Case Number: 1:2022cv00300
Filed: March 4, 2022
Court: US District Court for the District of Delaware
Presiding Judge: Maryellen Noreika
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 1 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on March 31, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
March 31, 2022 Opinion or Order SO ORDERED re #15 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to May 9, 2022 (Set/Reset Answer Deadlines: Boehringer Ingelheim Pharmaceuticals Inc. answer due 5/9/2022). ORDERED by Judge Maryellen Noreika on 3/31/2022. (dlw)
March 30, 2022 Filing 15 STIPULATION TO EXTEND TIME Respond to the Complaint to May 9, 2022 - filed by Cipla Ltd.. (Caponi, Steven)
March 30, 2022 Filing 14 WAIVER OF SERVICE returned executed by Cipla Ltd.: For Boehringer Ingelheim Pharma GmbH & Co. KG waiver sent on 3/9/2022, answer due 5/9/2022. (Caponi, Steven)
March 30, 2022 Filing 13 WAIVER OF SERVICE returned executed by Cipla Ltd.: For Boehringer Ingelheim International GmbH waiver sent on 3/9/2022, answer due 5/9/2022. (Caponi, Steven)
March 17, 2022 Pro Hac Vice Attorney Anil H. Patel for Cipla Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
March 15, 2022 Pro Hac Vice Attorney Melissa M Haulcomb, Peter L. Giunta, Jenna Bruce, and Harold M. Storey for Cipla Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
March 14, 2022 Filing 12 REDACTED VERSION of #2 Complaint, by Cipla Ltd.. (Attachments: #1 Exhibit B, #2 Exhibit C, #3 Exhibit D, #4 Exhibit H)(Caponi, Steven)
March 11, 2022 Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Anil H. Patel, Harold Storey, Jenna Bruce, Peter Giunta, and Melissa M. Haulcomb - filed by Cipla Ltd.. (Caponi, Steven)
March 11, 2022 Filing 10 SUMMONS Returned Executed by Cipla Ltd.. Boehringer Ingelheim Pharmaceuticals Inc. served on 3/9/2022, answer due 3/30/2022. (Caponi, Steven)
March 11, 2022 Opinion or Order SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Anil H. Patel, Harold Storey, Jenna Bruce, Peter Giunta, and Melissa M. Haulcomb filed by Cipla Ltd.. ORDERED by Judge Maryellen Noreika on 3/11/2022. (mdb)
March 9, 2022 Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb)
March 7, 2022 Opinion or Order Filing 9 ORDER Granting #1 MOTION to Seal. Signed by Judge Richard G. Andrews on 3/7/2022. (nms)
March 7, 2022 Filing 8 Summons Issued as to Boehringer Ingelheim International GmbH on 3/7/2022; Boehringer Ingelheim Pharma GmbH & Co. KG on 3/7/2022; Boehringer Ingelheim Pharmaceuticals Inc. on 3/7/2022. (Attachments: #1 Summons Issued, #2 Summons Issued)(mal)
March 7, 2022 Remark: Case submitted for routine judicial assignment. (mal)
March 7, 2022 Remark: Exit copies to Duty Judge (RGA) via e-mail. (mal)
March 4, 2022 Filing 7 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cipla Ltd.. (mal)
March 4, 2022 Filing 6 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,907,756 B2 ;10,105,323 B2. (mal)
March 4, 2022 Filing 5 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/6/2021. Date of Expiration of Patent: 06/07/2029. (mal)
March 4, 2022 Filing 4 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal)
March 4, 2022 Filing 3 EXHIBITS A, E-G and I-Q in support of #2 SEALED Complaint, by Cipla Ltd.. (Attachments: #1 Exhibit E-G, #2 Exhibit I-Q)(mal)
March 4, 2022 Filing 2 [SEALED] COMPLAINT filed against Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3818243.) - filed by Cipla Ltd.. (Attachments: #1 Exhibit B, #2 Exhibit C, #3 Exhibit D, #4 Exhibit H, #5 Civil Cover Sheet)(mal)
March 4, 2022 Filing 1 MOTION to Seal Complaint and Exhibits B-D, and Exhibit H - filed by Cipla Ltd.. (Attachments: #1 Text of Proposed Order)(mal)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Cipla Ltd.
Represented By: Steven L. Caponi
Represented By: Matthew B. Goeller
Represented By: Megan E. O'Connor
Represented By: Anil H. Patel
Represented By: Harold M. Storey
Represented By: Jenna Bruce
Represented By: Peter L. Giunta
Represented By: Melissa M Haulcomb
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Boehringer Ingelheim Pharmaceuticals Inc.
Represented By: Jack B. Blumenfeld
Represented By: Jeremy A. Tigan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Boehringer Ingelheim International GmbH
Represented By: Jack B. Blumenfeld
Represented By: Jeremy A. Tigan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Boehringer Ingelheim Pharma GmbH & Co. KG
Represented By: Jack B. Blumenfeld
Represented By: Jeremy A. Tigan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?